New RSV protections for infants hit cost, insurance hurdles in U.S. rollout
October 13, 2023 at 12:24 PM EDT
Pfizer's maternal vaccine, Abrysvo, and Sanofi's monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.
